Life Sciences & Healthcare Regulatory partner Howard Sklamberg was recently featured in the MarketWatch article, "These cannabis stocks have solid growth prospects — with help from the Biden administration." The article discusses the U.S. Department of Health and Human Services' (HHS) recommendation to move cannabis from Schedule I to Schedule III, which was issued in August of 2023.
The U.S. Department of Justice (DOJ) recently proposed a new rule for rescheduling, which Sklamberg said "will be published before this administration ends," adding that "it is quite possible it will be published well before that." Sklamberg told MarketWatch that there may be a need for a DOJ administrative law judge hearing on the proposed change, which would likely be done quickly and would mean that "they could publish a final rule by the fall."
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.